Advertisement

Picture [iito] No Tracking 650x80px
Organisation › Details

Catalent (Group)

Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs over 11,000 people, including over 1,800 scientists, at more than 30 facilities across five continents, and in fiscal year 2018 generated approximately $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit www.catalent.com. Catalent Biologics provides advanced technologies and integrated solutions for biologic and biosimilar development and manufacturing, from DNA to fill/finish and commercial supply, through its extensive Biologics network including: Bloomington, Indiana, where the company recently announced a twentieth commercial launch of a fill/finish product, and Madison, Wisconsin, home of Catalent Biologics’ proprietary GPEx® technology for stable, high-yielding mammalian cell lines with eleven approved molecules. *

 

Period Start 2011-08-13 existent
  Predecessor Cardinal Health (Group)
Products Industry drug discovery services
  Industry 2 contract manufacturing (drugs)
Person Person Chiminski, John (Catalent 201904 CEO)
     
  Street 14 Schoolhouse Road
  City 08873 Somerset, NJ
  Tel +1-877-587-1835
    Address record changed: 2020-12-02
     
Basic data Employees H: 10,001 to 50,00 (2018-05-14)
  Currency USD
  Annual sales 2,000,000,000 (revenue, annual (fiscal 2017) 2017-01-01)
     
    * Document for �About Section�: Catalent, Inc.. (4/15/19). "Press Release: Catalent to Acquire Gene Therapy Leader Paragon Bioservices, Inc. for $1.2 Billion". Somerset, NJ & Baltimore, MD.
     
   
Record changed: 2019-04-17

Advertisement

Picture ConsulTech GmbH RnD Credit Germany 650x80px

More documents for Catalent (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioTech Showcase 2021 Whitepaper Presenting 650x80




» top